Another reason to strong sell this junk:
Guru Score: 40%
PRICE/SALES RATIO: [FAIL]
The prospective company should have a low Price/Sales ratio. However, NAK's P/S is not available which means an opinion cannot be rendered at the present time on this variable. This is the most important variable according to this methodology, and therefore the remainder of the analysis will be provided for informational purposes.
TOTAL DEBT/EQUITY RATIO: [PASS]
Less debt equals less risk according to this methodology. NAK's Debt/Equity of 0.00% is exceptional, thus passing the test.
PRICE/RESEARCH RATIO: [PASS]
This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. NAK is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.
PRELIMINARY GRADE: No Interest in NAK At this Point
Is NAK a "Super Stock"? NO
LONG-TERM EPS GROWTH RATE: [FAIL]
This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. NAK's inflation adjusted EPS growth rate is not available. Hence, this methodology cannot analyze this criterion at the present time.
FREE CASH PER SHARE: [FAIL]
This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. NAK's free cash per share of -0.07 fails this criterion.
THREE YEAR AVERAGE NET PROFIT MARGIN: [FAIL]
This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. NAK's three year net profit margin, which averages 0.00%, does not pass this criterion.
Everything I say,is only my opinion. DO not rely on anything I post,as buy or sell advice. DO your own homework.
